HSBC Initiates Coverage On Eli Lilly with Buy Rating, Announces Price Target of $560
Portfolio Pulse from richadhand@benzinga.com
HSBC analyst Rajesh Kumar has initiated coverage on Eli Lilly (NYSE:LLY) with a Buy rating and a price target of $560.
July 14, 2023 | 8:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HSBC has initiated coverage on Eli Lilly with a Buy rating and a price target of $560, which could positively impact the company's stock.
The initiation of coverage by HSBC with a Buy rating indicates a positive outlook for Eli Lilly. The price target of $560 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100